🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

242 results for “Pfizer” Clear

  1. Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar sus

    Pfizer Australia Pty Ltd

    VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA

    approved small molecule active

    1 trial

  2. Apixaban

    Pfizer

    Atrial Fibrillation

    approved small molecule completed

    1 trial

  3. Atorvastatin

    Pfizer

    Dyslipidemias

    approved small molecule completed

    1 trial

  4. Braftovi 50 mg hard capsules, Zelboraf 240 mg film-coated tablets, Encorafenib, Erbitux 5 mg/mL solution for infusion, PEMBROLIZUMAB, Braftovi 75 mg hard capsules, Braftovi 75 mg hard capsules, Braftovi 50 mg hard capsules, Ribociclib, Ribociclib, NIVOLUMAB, Mektovi 15 mg film-coated tablets, Mektovi 15 mg film-coated tablets, Ribociclib

    Pfizer Australia Pty Ltd

    Solid tumors

    approved small molecule active

    1 trial

  5. Celecoxib

    Pfizer

    Arthritis, Juvenile Rheumatoid

    approved small molecule completed

    1 trial

  6. Etanercept

    Pfizer

    Moderate to Severe Psoriasis

    approved small molecule completed

    1 trial

  7. Etanercept , Methotrexate

    Wyeth is now a wholly owned subsidiary of Pfizer

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial

  8. LORLATINIB

    Pfizer Australia Pty Ltd

    Lung cancer

    approved small molecule active

    1 trial

  9. Pfizer-BioNTech mRNA COVID-19 vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    COVID -19

    approved small molecule active

    1 trial

  10. Placebo for Rimegepant 75 mg, VYDURA 75 mg oral lyophilisate

    Pfizer Australia Pty Ltd

    migraine headaches with or without aura

    approved small molecule active

    1 trial

  11. Pregabalin

    Pfizer

    Bone Neoplasms

    approved small molecule terminated

    1 trial

  12. ReFacto

    Wyeth is now a wholly owned subsidiary of Pfizer

    Hemophilia A

    approved small molecule terminated

    1 trial

  13. Sildenafil citrate

    Pfizer

    Pulmonary Arterial Hypertension

    approved small molecule terminated

    1 trial

  14. Tigecycline

    Wyeth is now a wholly owned subsidiary of Pfizer

    Skin Diseases, Bacterial

    approved small molecule completed

    1 trial

  15. Tofacitinib with methotrexate

    Pfizer

    Rhematoid Arthritis

    approved small molecule completed

    1 trial

  16. VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg

    Pfizer Australia Pty Ltd

    Migraine attacks with or without aura

    approved small molecule active

    1 trial

  17. XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules

    Pfizer Australia Pty Ltd

    This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed

    approved small molecule active

    1 trial

  18. Zavicefta, Ceftazidime-Avibactam

    Pfizer

    Hospital-Acquired Pneumonia

    approved small molecule completed

    1 trial

  19. cyclosporine or tacrolimus

    Wyeth is now a wholly owned subsidiary of Pfizer

    Graft Rejection

    approved small molecule completed

    1 trial

  20. dexmedetomidine

    Pfizer

    MRI Sedation

    approved small molecule completed

    1 trial

  21. inotuzumab ozogamicin-dose level 2

    Pfizer

    Leukemia

    approved small molecule completed

    1 trial

  22. pregabalin

    Pfizer

    Diabetic Neuropathy, Painful

    approved small molecule completed

    1 trial

  23. pregabalin and celecoxib

    Pfizer

    Chronic Low Back Pain With a Neuropathic Component

    approved small molecule terminated

    1 trial

  24. temsirolimus

    Pfizer

    Non-Hodgkin's Lymphoma

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources